Short and Long-Term Effectiveness of Existing Insomnia Therapies for Patients Undergoing Hemodialysis
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 126 participants.
Also called NCT03534284
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 126 participants
- Registry
-
NCT03534284
-
- Other papers using this trial's data
- Effectiveness of Existing Insomnia Therapies for Patients Undergoing Hemodialysis : A Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT03534284. Randomized; triple masking; primary purpose treatment. Start 2018-09-19 (actual); primary completion 2022-10-17 (actual). Results posted on 2024-02-05.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Short and Long-Term Effectiveness of Existing Insomnia Therapies for Patients Undergoing Hemodialysis
- Acronym
- Sleep-HD
- Condition
- Insomnia
- Condition
- End Stage Renal Disease
- Intervention (Behavioral)
- Cognitive Behavioral Therapy for Insomnia
- Intervention (Drug)
- Trazodone
- Intervention (Drug)
- Placebo
- Lead sponsor
- University of Washington
- Collaborator
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Record details
- Record id
cardio:ct-nct03534284- Content hash
562ca9aa768a7b1a3124db0da617996105d9ca6bc818a5de9a696ab439160f11